Louis M. Weiner, MD
MedStar Health, the largest not-for-profit health-care system across Maryland and the Washington, DC, region, has named Louis M. Weiner, MD, as Director of its MedStar Georgetown Cancer Institute. Dr. Weiner will serve in this capacity while also remaining Director of Georgetown Lombardi Comprehensive Cancer Center, Washington’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center.As Director of the MedStar Georgetown Cancer Institute, Dr. Weiner will lead the development and coordination of clinical care and research programs spanning prevention, treatment, rehabilitation, survivorship, and end-of-life care across the MedStar Health system.
The integration of MedStar Health’s clinical care and Georgetown Lombardi’s robust research platform will bring advanced cancer care, greater access to clinical trials, and state-of-the-art technologies to patients at more convenient locations. It is a direct outgrowth of the continuing collaborations of Georgetown University and MedStar Health, reflected by a recent agreement to extend and enrich existing interactions between the two enterprises.
Leadership Positions
An internationally recognized medical oncologist specializing in the treatment of gastrointestinal cancers, Dr. Weiner is an accomplished researcher who focuses on monoclonal antibody research and other immunotherapy treatments. He serves as Chair of the NCI’s Board of Scientific Counselors and as a member of its Clinical Trials Advisory Committee. In addition, Dr. Weiner recently concluded service as a member of the Advisory Panel of the National Institutes of Health (NIH) Center for Scientific Research, which administers NIH research grants. Prior to his appointment as Georgetown Lombardi Director in 2007, Dr. Weiner held several leadership positions at Fox Chase Cancer Center in Philadelphia. ■
